cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.14603026
title: Global Aesthetics Injectables Market 2024 To 2033

description: Aesthetics Injectables Market Size, Trends and Insights By Product Type (Botulinum Toxin, Dermal Fillers, Collagen Stimulators, Others), By Application (Facial Line Correction, Lip Augmentation, Facial Volume Restoration, Wrinkle Reduction, Others), By Gender (Male, Female), By End-User (Hospitals, Dermatology Clinics, Cosmetic Centers, Ambulatory Surgical Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Aesthetics Injectables Market is expected to record a CAGR of 9.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 15,509.4 Million. By 2033, the valuation is anticipated to reach USD 35,976.2 Million.

The aesthetics injectables market encompasses a diverse range of non-invasive cosmetic treatments aimed at enhancing facial aesthetics and addressing signs of aging. These treatments include botulinum toxin injections, dermal fillers, and collagen stimulators, among others.

With a growing aging population, increasing beauty consciousness, and advancements in product formulations and delivery techniques, the aesthetics injectables market continues to expand globally. Key drivers include the demand for minimally invasive procedures, rising disposable incomes, and the influence of social media and celebrity endorsements, contributing to sustained growth in the market.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=51057
DOI: 10.5281/zenodo.14603027
title: Global Aesthetics Injectables Market 2024 To 2033

description: Aesthetics Injectables Market Size, Trends and Insights By Product Type (Botulinum Toxin, Dermal Fillers, Collagen Stimulators, Others), By Application (Facial Line Correction, Lip Augmentation, Facial Volume Restoration, Wrinkle Reduction, Others), By Gender (Male, Female), By End-User (Hospitals, Dermatology Clinics, Cosmetic Centers, Ambulatory Surgical Centers, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Aesthetics Injectables Market is expected to record a CAGR of 9.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 15,509.4 Million. By 2033, the valuation is anticipated to reach USD 35,976.2 Million.

The aesthetics injectables market encompasses a diverse range of non-invasive cosmetic treatments aimed at enhancing facial aesthetics and addressing signs of aging. These treatments include botulinum toxin injections, dermal fillers, and collagen stimulators, among others.

With a growing aging population, increasing beauty consciousness, and advancements in product formulations and delivery techniques, the aesthetics injectables market continues to expand globally. Key drivers include the demand for minimally invasive procedures, rising disposable incomes, and the influence of social media and celebrity endorsements, contributing to sustained growth in the market.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=51057
DOI: 10.15468/dl.ce7bhg
title: Occurrence Download

description: A dataset containing 24579 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Caretta caretta (Linnaeus, 1758)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 24579 records from 12 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057610-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.w7w2b8
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Testudo caretta Linnaeus, 1758",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057611-241126133413365/datasets/export for details.
DOI: 10.15468/dl.82wvya
title: Occurrence Download

description: A dataset containing 255 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Hemitrygon akajei (Müller & Henle, 1841)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 255 records from 33 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057612-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14603038
title: Global Pharmaceutical CRM Software Market 2024 To 2033

description: Pharmaceutical CRM Software Market Size, Trends and Insights By Deployment Type (On-Premises CRM Software, Cloud-Based CRM Software), By Application (Customer Relationship Management, Sales Force Automation, Marketing Automation, Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Pharmaceutical CRM Software Market is expected to record a CAGR of 4.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4,356.3 Million. By 2033, the valuation is anticipated to reach USD 6,643.1 Million.

The Pharmaceutical CRM Software Market refers to the global industry focused on providing software solutions tailored to the specific needs of pharmaceutical companies for customer relationship management (CRM). These software solutions enable pharmaceutical companies to effectively manage interactions with healthcare professionals (HCPs), track sales activities, and optimize marketing strategies.

With features such as real-time data analytics, personalized engagement tools, and compliance management capabilities, Pharmaceutical CRM Software empowers companies to enhance customer engagement, improve sales force effectiveness, and drive business growth in the highly regulated and competitive pharmaceutical industry landscape.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50988
DOI: 10.5281/zenodo.14603039
title: Global Pharmaceutical CRM Software Market 2024 To 2033

description: Pharmaceutical CRM Software Market Size, Trends and Insights By Deployment Type (On-Premises CRM Software, Cloud-Based CRM Software), By Application (Customer Relationship Management, Sales Force Automation, Marketing Automation, Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Pharmaceutical CRM Software Market is expected to record a CAGR of 4.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4,356.3 Million. By 2033, the valuation is anticipated to reach USD 6,643.1 Million.

The Pharmaceutical CRM Software Market refers to the global industry focused on providing software solutions tailored to the specific needs of pharmaceutical companies for customer relationship management (CRM). These software solutions enable pharmaceutical companies to effectively manage interactions with healthcare professionals (HCPs), track sales activities, and optimize marketing strategies.

With features such as real-time data analytics, personalized engagement tools, and compliance management capabilities, Pharmaceutical CRM Software empowers companies to enhance customer engagement, improve sales force effectiveness, and drive business growth in the highly regulated and competitive pharmaceutical industry landscape.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50988
DOI: 10.15468/dl.f7ncmh
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Trygon akajei Müller & Henle, 1841",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057613-241126133413365/datasets/export for details.
DOI: 10.15468/dl.6ngdq7
title: Occurrence Download

description: A dataset containing 194 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Dasyatis akajei (Müller & Henle, 1841)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 194 records from 27 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057614-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9bgytu
title: Occurrence Download

description: A dataset containing 39 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Neotrygon kuhlii (Müller & Henle, 1841)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 39 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057615-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14603054
title: US Cell Separation Market 2024 To 2033

description: US Cell Separation Market Size, Trends and Insights By Product (Consumables, Instruments, Others), By Technology (Centrifugation, Surface Marker, Filtration), By Application (Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Others), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

US Cell Separation Market was valued at USD 3.8 Billion in 2024 and is expected to reach USD 7.8 Billion by 2033, at a CAGR of 6.3% during the forecast period 2024 – 2033.

Cell separation, also known as cell sorting or cell isolation, is a process used to separate specific cell populations from a heterogeneous mixture. This technique is crucial in various fields such as biotechnology, medicine, and research.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50445
DOI: 10.5281/zenodo.14603055
title: US Cell Separation Market 2024 To 2033

description: US Cell Separation Market Size, Trends and Insights By Product (Consumables, Instruments, Others), By Technology (Centrifugation, Surface Marker, Filtration), By Application (Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Others), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

US Cell Separation Market was valued at USD 3.8 Billion in 2024 and is expected to reach USD 7.8 Billion by 2033, at a CAGR of 6.3% during the forecast period 2024 – 2033.

Cell separation, also known as cell sorting or cell isolation, is a process used to separate specific cell populations from a heterogeneous mixture. This technique is crucial in various fields such as biotechnology, medicine, and research.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=50445
DOI: 10.34740/kaggle/dsv/10371244
title: Fine Tuning Dataset in Tamil literature domain
DOI: 10.15468/dl.ncxc9t
title: Occurrence Download

description: A dataset containing 11 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Dasyatis bennettii (Müller & Henle, 1841)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 11 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057616-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dwfsz8
title: Occurrence Download

description: A dataset containing 28 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Metapenaeopsis barbata (De Haan, 1844)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 28 records from 6 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057618-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.z93tt2
title: Occurrence Download

description: A dataset containing 13 species occurrences available in GBIF matching the query:
{
 "and" : [
 "CoordinateUncertaintyInMeters 0.0-1000.0",
 "Country is Nepal",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Canis lupus Linnaeus, 1758"
 ]
}

 The dataset includes 13 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057619-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qf2xry
title: Occurrence Download

description: A dataset containing 323 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Anadara broughtonii (Schrenck, 1867)",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 323 records from 29 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057620-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14603066
title: Global Mammalian Polyclonal IgG Antibody Market 2024 To 2033

description: Mammalian Polyclonal IgG Antibody Market Size, Trends and Insights By Type (Goat, Rabbit, Horse, Mouse, Others), By Product (Cardiac Markers, Metabolic Markers, Renal Markers, Others), By Application (ELISA, Immunoturbidometry, Immunoelectrophoresis, Antibody Identification, Immunohistochemistry, Immunocytochemistry, Western Blotting, Others), By End Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by CMI Team, the global Mammalian Polyclonal IgG Antibody Market is expected to record a CAGR of 4.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 2,272.6 Million. By 2033, the valuation is anticipated to reach USD 3,465.6 Million.

The mammalian polyclonal IgG antibody market encompasses a dynamic sector within the biotechnology industry, focused on producing and commercialising antibodies derived from mammalian sources. These antibodies, characterized by their diverse antigen recognition capabilities, find widespread applications in research, diagnostics, and therapeutics.

With increasing demand for high-quality life sciences and healthcare reagents, the market continues to expand. Key players, leveraging advancements in biotechnology and strategic collaborations, drive innovation in antibody development and production. This market is vital in advancing biomedical research, clinical diagnostics, and therapeutic interventions.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=51177
DOI: 10.5281/zenodo.14603067
title: Global Mammalian Polyclonal IgG Antibody Market 2024 To 2033

description: Mammalian Polyclonal IgG Antibody Market Size, Trends and Insights By Type (Goat, Rabbit, Horse, Mouse, Others), By Product (Cardiac Markers, Metabolic Markers, Renal Markers, Others), By Application (ELISA, Immunoturbidometry, Immunoelectrophoresis, Antibody Identification, Immunohistochemistry, Immunocytochemistry, Western Blotting, Others), By End Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by CMI Team, the global Mammalian Polyclonal IgG Antibody Market is expected to record a CAGR of 4.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 2,272.6 Million. By 2033, the valuation is anticipated to reach USD 3,465.6 Million.

The mammalian polyclonal IgG antibody market encompasses a dynamic sector within the biotechnology industry, focused on producing and commercialising antibodies derived from mammalian sources. These antibodies, characterized by their diverse antigen recognition capabilities, find widespread applications in research, diagnostics, and therapeutics.

With increasing demand for high-quality life sciences and healthcare reagents, the market continues to expand. Key players, leveraging advancements in biotechnology and strategic collaborations, drive innovation in antibody development and production. This market is vital in advancing biomedical research, clinical diagnostics, and therapeutic interventions.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=51177
DOI: 10.15468/dl.fw6d9u
title: Occurrence Download

description: A dataset containing 425 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sphyraena pinguis Günther, 1874",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 425 records from 19 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057621-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.e64vey
title: Occurrence Download

description: A dataset containing 122 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sphyraena obtusata Cuvier, 1829",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 122 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057623-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.xctb3z
title: Occurrence Download

description: A dataset containing 257 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Hippoglossoides dubius Schmidt, 1904",
 "Geometry POLYGON((170 20, 170 50, 120 50, 120 20, 170 20))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 257 records from 12 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057624-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5517/ccdc.csd.cc2jrfwm
title: CCDC 2346231: Experimental Crystal Structure Determination

description: Related Article: Andrew I. VanderWeide, Hagen Neugebauer, Bhumika Goel, David S. Tresp, Deuris Pena, Stefan Grimme, Andreas Hansen, Demyan E. Prokopchuk|2024|Organometallics|43|3143|doi:10.1021/acs.organomet.4c00137
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2jrfxn
title: CCDC 2346232: Experimental Crystal Structure Determination

description: Related Article: Andrew I. VanderWeide, Hagen Neugebauer, Bhumika Goel, David S. Tresp, Deuris Pena, Stefan Grimme, Andreas Hansen, Demyan E. Prokopchuk|2024|Organometallics|43|3143|doi:10.1021/acs.organomet.4c00137
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2jrfyp
title: CCDC 2346233: Experimental Crystal Structure Determination

description: Related Article: Andrew I. VanderWeide, Hagen Neugebauer, Bhumika Goel, David S. Tresp, Deuris Pena, Stefan Grimme, Andreas Hansen, Demyan E. Prokopchuk|2024|Organometallics|43|3143|doi:10.1021/acs.organomet.4c00137
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.15468/dl.nuqgf6
title: Occurrence Download

description: A dataset listing the 2770 species recorded in GBIF matching the query:
{
 "TaxonKey" : [
 "is Rhododendron L."
 ]
}

 The dataset's 2770 records were derived from 1391 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057617-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.xsnjio
title: Occurrence Download

description: A dataset containing 983575470 species occurrences available in GBIF matching the query:
{ }

 The dataset includes 983575470 records from 19570 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022480-180508205500799/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.